ASO Platform End to end antisense oligonucleotide development platform enables RNA therapeutic programs from design to synthesis, addressing stability and targeted delivery challenges. This creates a compelling option for biotech and pharma teams seeking faster lead optimization and a single vendor workflow.

Immunotherapy Capabilities Comprehensive cell therapy and immunotherapy services, including comprehensive cell based artificial T-cell stimulator development, support early and advanced discovery for oncology and immune related targets. Opportunities exist to partner with startups and mid sized biotechs building T-cell based therapies or immuno oncology pipelines.

Neurodegenerative Models Expanded preclinical neuroscience portfolio with advanced in vitro AD and PD models and experimental autoimmune encephalomyelitis (EAE) models to accelerate neurodegenerative drug discovery. Ideal for pharma and academia needing reliable disease models and assay ready assets.

AI Driven Discovery AI driven drug discovery enhancements coupled with tailored next generation sequencing solutions for complex 3D biology provide data rich insights and scalable workflows. Pitch to companies pursuing data driven discovery and challenging target landscapes.

Global Outsourcing Edge Cost effective outsourcing with a global client base across biopharma, biotech, government and academic labs. Flexible project teams and rapid delivery make Creative Biolabs a practical partner for mid sized programs seeking predictable timelines and value.